Correlation Between Aridis Pharmaceuticals and Transgene
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Transgene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Transgene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Transgene SA, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Transgene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Transgene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Transgene.
Diversification Opportunities for Aridis Pharmaceuticals and Transgene
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aridis and Transgene is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Transgene SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transgene SA and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Transgene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transgene SA has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Transgene go up and down completely randomly.
Pair Corralation between Aridis Pharmaceuticals and Transgene
If you would invest 159.00 in Transgene SA on August 24, 2024 and sell it today you would earn a total of 0.00 from holding Transgene SA or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 4.55% |
Values | Daily Returns |
Aridis Pharmaceuticals vs. Transgene SA
Performance |
Timeline |
Aridis Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Transgene SA |
Aridis Pharmaceuticals and Transgene Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aridis Pharmaceuticals and Transgene
The main advantage of trading using opposite Aridis Pharmaceuticals and Transgene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Transgene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transgene will offset losses from the drop in Transgene's long position.Aridis Pharmaceuticals vs. Akari Therapeutics PLC | Aridis Pharmaceuticals vs. Aditxt Inc | Aridis Pharmaceuticals vs. ABVC Biopharma | Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |